Not Found

Find information on medical topics, symptoms, drugs, procedures, news and more, written for the health care professional.

Thin Basement Membrane Disease

(Benign Familial Hematuria)

By Navin Jaipaul, MD, MHS, Associate Professor of Medicine; Chief, Nephrology, Loma Linda University School of Medicine; VA Loma Linda Healthcare System

Click here for
Patient Education

Thin basement membrane disease is diffuse thinning of the glomerular basement membrane from a width of 300 to 400 nm in normal subjects to 150 to 225 nm.

Thin basement membrane disease is a type of nephritic syndrome. It is hereditary and usually transmitted in autosomal dominant fashion. Not all genetic mutations have been characterized, but in some families with thin basement membrane disease there is a mutation in the type IV collagen α4 gene. Prevalence is estimated to be 5 to 9%.

Symptoms and Signs

Most patients are asymptomatic and are incidentally noted to have microscopic hematuria on routine urinalysis, although mild proteinuria and gross hematuria are occasionally present. Renal function is typically normal, but a few patients develop progressive renal failure for unknown reasons. Recurrent flank pain, similar to that in IgA nephropathy, is a rare manifestation.


  • Clinical evaluation

  • Sometimes renal biopsy

Diagnosis is based on family history and findings of hematuria without other symptoms or pathology, particularly if asymptomatic family members also have hematuria. Renal biopsy is unnecessary but is often done as part of a hematuria evaluation. Early on, thin basement membrane disease may be difficult to differentiate from hereditary nephritis because of histologic similarities.


  • For frequent gross hematuria, flank pain, or proteinuria, ACE inhibitors or angiotensin II receptor blockers

Long-term prognosis is excellent, and no treatment is necessary in most cases. Patients with frequent gross hematuria, flank pain, or proteinuria (eg, urine protein/creatinine ratio of > 0.2) may benefit from ACE inhibitors or angiotensin receptor II blockers, which may lower intraglomerular pressure.

Resources In This Article